(object) array( 'id' => '1461055', 'url' => 'SR/side_effects', 'image' => '', 'title' => 'neželjena dejstva', 'tags' => array ( 0 => 'neželjena dejstva', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'neželjena dejstva', 'source_id' => 30937, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705160004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sva neželjena dejstva ili uticaji leka ili lečenja. Negativna ili štetna dejstva mogu podrazumevati glavobolju, mučninu, opadanje kose, iritaciju kože ili druge fizičke probleme. Mora se odmah izvršiti procena i trenutnih i dugotrajnih neželjenih dejstava eksperimentalnog leka.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966611554304, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'side effects', 'Definition' => 'Any undesired actions or effects of a drug or treatment. Negative or adverse effects may include headache, nausea, hair loss, skin irritation, or other physical problems. Experimental drugs must be evaluated for both immediate and long-term side effects.', 'Synonym' => 'adverse_reaction', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'side_effects', )

(object) array( 'id' => '1467655', 'url' => 'SR/Lamictal', 'image' => '', 'title' => 'Lamictal', 'tags' => array ( 0 => 'Lamictal', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamictal', 'source_id' => 31148, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju epilepsije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845761, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamictal', 'Definition' => 'a prescription drug used to treat epilepsy', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamictal', )

(object) array( 'id' => '1461320', 'url' => 'SR/market_positioning', 'image' => '', 'title' => 'pozocioniranje na tržištu', 'tags' => array ( 0 => 'pozocioniranje na tržištu', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'pozocioniranje na tržištu', 'source_id' => 57180, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225508', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj izdvajanja proizvoda od drugih konkurentskih sličnim njemu, stvarajući utisak o jedinstvenosti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967784910848, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market positioning', 'Definition' => 'An attempt to distinguish a product from its similar competitors by creating a perception of uniqueness.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/18', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/18', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_positioning', )

(object) array( 'id' => '1461051', 'url' => 'SR/prevention_trials', 'image' => '', 'title' => 'Ipitivanja prevencije', 'tags' => array ( 0 => 'Ipitivanja prevencije', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Ipitivanja prevencije', 'source_id' => 30922, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155513', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na ispitivanja koja za cilj imaju pronalaženje boljih načina za prevenciju bolesti kod ljudi koji nikada nisu oboljevali ili prevenciju povratka bolesti. Ovi pristupi mogu podrazumevati lekove, vakcine, vitamine, minerale ili promene načina života.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966610505728, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'prevention trials', 'Definition' => 'Refers to trials to find better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicines, vaccines, vitamins, minerals, or lifestyle changes.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'prevention_trials', )

(object) array( 'id' => '1460563', 'url' => 'SR/approved_drugs', 'image' => '', 'title' => 'odobreni lekovi', 'tags' => array ( 0 => 'odobreni lekovi', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'odobreni lekovi', 'source_id' => 30872, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U Sjedinjenim Državama, Zavod za zaštitu zdravlja (FDA) mora odobriti supstancu kao lek pre nego bude pušten na tržište. Ovaj proces podrazumeva nekoliko stadijuma uključujući prekliničke laboratorijske studije i studije na životinjama, kliničko testiranje bezbednosti i efikasnosti proizvoda, popunjavanje Prijuave za registraciju novog leka od strane proizvođača samog leka, pregled prijave od strane FDA i odobrenje/odbijanje prijave od strane FDA', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325249, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'approved drugs', 'Definition' => 'In the U.S., the Food and Drug Administration (FDA) must approve a substance as a drug before it can be marketed. The approval process involves several steps including pre-clinical laboratory and animal studies, clinical trials for safety and efficacy, filing of a New Drug Application by the manufacturer of the drug, FDA review of the application, and FDA approval/rejection of application.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'approved_drugs', )

(object) array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', )

(object) array( 'id' => '1461305', 'url' => 'SR/employee_empowerment', 'image' => '', 'title' => 'osnaživanje zaposlenih', 'tags' => array ( 0 => 'osnaživanje zaposlenih', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'osnaživanje zaposlenih', 'source_id' => 40076, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Ovaj izraz se koriti da izrazi način na koji ne-upravni sektor može doneti esencijalne odluke bez konsultacije šefa/menadžera.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765124, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'employee empowerment', 'Definition' => 'A term used to express the manners in which non-managerial staff can make essential decisions without consulting a boss/manager.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'employee_empowerment', )

(object) array( 'id' => '1460562', 'url' => 'SR/pharmaceuticals', 'image' => '', 'title' => 'lekovi', 'tags' => array ( 0 => 'lekovi', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'lekovi', 'source_id' => 114398, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Hemijska supstanca koja se koristi u medicinske svrhe, uključujući dijagnostiku, lečenje ili prevenciju bolesti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325248, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'pharmaceuticals', 'Definition' => 'Chemical substance for medical purposes, including diagnosis, treatment and prevention of disease.', 'Synonym' => 'medicine_₀', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Drugs', 'Industry' => 'Pharmaceutical', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/7/20', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'pharmaceuticals', )

(object) array( 'id' => '1461088', 'url' => 'SR/convention_₅', 'image' => '', 'title' => 'konvencija', 'tags' => array ( 0 => 'konvencija', 1 => 'Language', 2 => 'Terminology', 3 => '', ), 'term' => 'konvencija', 'source_id' => 1080723, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163519', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sporazum, uglavnom jednosglasno postignut od strane govornika zajednice, da se povezanost mora primenjivati između lingvističkih jedinica, između ovih i dpoljnog sveta ili primeniti pri upotrebi gramatičkih pravila datij jezika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797187, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'convention', 'Definition' => 'An agreement, usually reached unconsciously by speakers in a community, that relationships are to apply between linguistic items, between these and the outside world or to apply in the use of rules in the grammar of their language.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'convention_₅', )

(object) array( 'id' => '1461050', 'url' => 'SR/phase_iv_trials', 'image' => '', 'title' => 'Četvrta faza ispitivanja', 'tags' => array ( 0 => 'Četvrta faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Četvrta faza ispitivanja', 'source_id' => 30919, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155512', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Postmarketinške studije za prezentovanje dodatnih informacija uključujući rizike leka, koristi i optimalna upotreba.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966609457152, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iv trials', 'Definition' => 'Post-marketing studies to delineate additional information including the drug\'s risks, benefits, and optimal use.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iv_trials', )